HSCA Comments to FDA Regarding FDA’s List of Public Health Focused Essential Medicines
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments to the U.S. Food and Drug Administration (FDA) regarding FDA’s recently published list of essential medicines, medical countermeasures (MCM), and their critical inputs. HSCA and our member companies are committed to ensuring continued patient access to critical medical products.
Click here to read the full comments.
Related Posts
HSCA Comments to FDA Regarding FDA’s List of Public Health Focused Essential Medicines
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...
HSCA Comments to the Senate Committee on Health, Education, Labor, and Pensions on the PREVENT Pandemics Act
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the...
HSCA ANNOUNCES 2022 BOARD OF DIRECTORS AND NAMES CHILDREN’S HOSPITAL ASSOCIATION VICE PRESIDENT JENNIFER GEDNEY BOARD CHAIR
Washington, DC (January 4, 2022) – The Healthcare Supply Chain Association (HSCA)...
HSCA Statement on Senate HELP Committee Hearing on the Coronavirus
Washington, DC (March 3, 2020) – Healthcare Supply Chain Association (HSCA)...